Aspenwood Dental Associates and Colorado Dental Implant Center, an independent Aurora dental practice operating since 1972, is drawing attention to published clinical guidance on the oral effects of GLP-1 medications, which 11% of U.S. adults now take for weight loss.
Gallup reported on July 7, 2026, that 11% of U.S. adults currently take GLP-1 medications such as semaglutide or tirzepatide for weight loss, up from 3% in 2024. Another 15% report having used them at some point, and 91% are aware of the drug class. The figures come from a web survey of 5,065 U.S. adults conducted May 28 through June 5, 2026, as part of the Gallup National Health and Well-Being Index. Adoption at that scale means general dental practices along Colorado's Front Range, including those serving Aurora, Centennial and the wider Denver metro area, now see a patient population taking these medications that barely existed three years ago.
The dental literature describes the connection between these drugs and oral health as indirect. A review by Karina Kofman and Aviv Ouanounou, published April 10, 2026, in the Canadian Journal of Diabetes, found no published evidence that semaglutide acts directly on enamel, dentin, pulp or the periodontal ligament. The authors instead attribute oral findings to secondary mechanisms: xerostomia, or dry mouth; halitosis; enamel erosion associated with vomiting; and altered taste. They recommend that clinicians monitor patients beginning semaglutide for dry mouth and apply preventive measures against cavities, root cavities and gingivitis.
The same review is explicit about the limits of the evidence, noting that its clinical signs and management recommendations rest on case reports, case series and extrapolation from established dental science rather than large clinical trials. That distinction matters for patients. The guidance describes increased susceptibility under certain conditions, not a demonstrated increase in cavities among everyone taking the medication. The American Dental Association published comparable guidance for dental teams in October 2025, in which a continuing education presenter encouraged clinicians to ask about medication use during intake, to discuss diet and nutrition with patients experiencing rapid weight loss and to reinforce consistent hygiene to counteract shifts in oral pH and microbiome balance.
Saliva neutralizes acid, clears food debris and returns minerals to enamel, which is why reduced salivary flow has long been treated as a risk factor in dentistry regardless of its cause. The practical issue the guidance identifies is a communication gap rather than a drug hazard: a GLP-1 prescription typically comes from a primary care physician or specialist, and patients do not always mention it at a dental visit. Substantial weight loss can also change how removable appliances such as dentures and night guards fit, a change patients often notice before a dentist does. The published guidance centers on straightforward measures, including hydration, consistent brushing and flossing and professional monitoring, rather than discontinuing a prescribed medication, which remains a decision for the prescribing physician.
Aspenwood Dental Associates and Colorado Dental Implant Center has operated at the same address on South Peoria Street since 1972 and has four dentists on staff. Lisa Augustine, DDS, has practiced there since 1996.
Patients taking a GLP-1 medication who want to understand how dry mouth and enamel protection are addressed during preventive hygiene can read the practice's published protocol for dental cleanings in Aurora, Colorado, at https://aspenwooddental.com/general-dentistry/dental-cleanings/.
This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider for personal health decisions.
About Aspenwood Dental Associates and Colorado Dental Implant Center
Aspenwood Dental Associates and Colorado Dental Implant Center is an independently owned dental practice in Aurora, Colorado, established in 1972. Four dentists provide general, cosmetic, restorative, implant and sedation dentistry at a single location, including Lisa Augustine, DDS, in practice since 1996. The office is located at 2900 S Peoria St Ste C, Aurora, CO 80014, and can be reached at (303) 731-4037 or https://www.aspenwooddental.com.
###
For more information about Aspenwood Dental Associates and Colorado Dental Implant Center, contact the company here:
Aspenwood Dental Associates and Colorado Dental Implant Center
Dr. Ronald Yaros
3037314037
info@aspenwooddental.com
M563+XC Aurora, Colorado, USA